Literature DB >> 12434839

Cognitive changes following subthalamic nucleus stimulation in two patients with Parkinson disease.

Rita Moretti1, Paola Torre, Rodolfo M Antonello, Livio Capus, Manuela Gioulis, Sandro Zambito Marsala, Giuseppe Cazzato, Antonio Bava.   

Abstract

The limits of a drug therapy in severe forms of Parkinson disease have led to refining neurosurgery on the basal ganglia. Deep brain stimulation of the subthalamic nucleus has been recognized as one of the most promising techniques to decrease "off" motor symptoms and motor fluctuations, allowing a reduction of drug therapy and limiting side effects of the drugs. There is still open debate on the possible consequences of chronic subthalamic stimulation in other ways, apart from motor symptoms, of general cognitive performance. We examined and followed two patients with Parkinson disease for 9 mo. after surgery for deep stimulation, studying their cognitive performances. There is a general amelioration of cognitive performances, in particular as far as linguistic capabilities is concerned. We discuss the possible significance of these results, reminding strenuously that only two patients were involved, so the potential for generalization is seriously limited.

Entities:  

Mesh:

Year:  2002        PMID: 12434839     DOI: 10.2466/pms.2002.95.2.477

Source DB:  PubMed          Journal:  Percept Mot Skills        ISSN: 0031-5125


  2 in total

1.  Differential effects of subthalamic nucleus stimulation in advanced Parkinson disease on reaction time performance.

Authors:  Yasin Temel; Arjan Blokland; Linda Ackermans; Peter Boon; Vivianne H J M van Kranen-Mastenbroek; E A M Beuls; Geert H Spincemaille; Veerle Visser-Vandewalle
Journal:  Exp Brain Res       Date:  2005-11-05       Impact factor: 1.972

2.  A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease.

Authors:  Sara Piccoli; Giulia Perini; Silvia Pizzighello; Alec Vestri; Giovanni Ferri; Tommaso Toffanin; Halima Follador; Andrea Martinuzzi
Journal:  Psychiatry Investig       Date:  2015-01-12       Impact factor: 2.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.